{
    "Case ID": "078194",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent validity and infringement"
    ],
    "Legal_Issue": [
        "Should Apotex be awarded full costs as the successful party?"
    ],
    "Governing_Law": [
        "Federal Courts Rules, Rule 400(3)"
    ],
    "Procedural_Stage": [
        "Trial followed by cost submissions"
    ],
    "Evidence_Assessment": [
        "26-day trial with extensive evidence and expert testimony"
    ],
    "Decision_Outcome": [
        "Apotex awarded 80% of its costs at the upper end of Column IV"
    ],
    "Burden_of_Proof": [
        "On Apotex to justify full costs; on Sanofi to oppose"
    ],
    "Credibility_Factor": [
        "Expert testimony evaluated for reliability and relevance"
    ],
    "Legal_Rule": [
        "Cost allocation based on result, complexity, and public interest"
    ],
    "Standard_of_Review": [
        "Judicial discretion under Federal Courts Rules"
    ],
    "Procedural_Issue": [
        "Appropriate level of costs given partial success and complexity"
    ],
    "Grounds_for_Claim": [
        "Invalidity of Sanofi's patent and infringement by Apotex"
    ],
    "Outcome_on_Merits": [
        "Sanofi's patent invalidated; Apotex found infringing"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Costs awarded with 20% reduction due to partial success"
    ],
    "Review_Standard": [
        "Reasonableness and proportionality in cost awards"
    ],
    "Procedural_Fairness_Assessment": [
        "Both parties submitted arguments on costs; court considered all factors"
    ],
    "Key_Evidence_Considered": [
        "Expert testimony, trial record, duration and complexity of proceedings"
    ],
    "Legal_Framework": [
        "Federal Courts Rules, Tariff B (Columns III and IV)"
    ],
    "Applicant_Challenge": [
        "Apotex sought full costs under Column IV"
    ],
    "Court_Result": [
        "80% of costs awarded at upper end of Column IV"
    ],
    "Legal_Rule_Source": [
        "Federal Courts Rules"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Sanofi argued for Column III and 50% reduction in costs"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert reports, trial testimony"
    ],
    "Remedy_Requested": [
        "Full recovery of legal costs by Apotex"
    ],
    "Outcome": [
        "Partial cost recovery granted"
    ],
    "Decision_Authority": [
        "Federal Court judge presiding over the trial"
    ],
    "Remedy_Sought": [
        "Costs under Column IV of Tariff B"
    ],
    "Resolution_Mechanism": [
        "Judicial determination following post-trial submissions"
    ],
    "Legal_Provision": [
        "Rule 400(3) of the Federal Courts Rules"
    ],
    "Authority": [
        "Federal Court of Canada"
    ],
    "Claimant_Status": [
        "Apotex as successful challenger and defendant on counterclaim"
    ],
    "Legal_Provision_Cited": [
        "Federal Courts Rules, Rule 400(3); Tariff B"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Patent invalidity and infringement"
    ],
    "Applicable_Process": [
        "Adversarial litigation process"
    ],
    "Outcome_of_Review": [
        "Costs adjusted to reflect partial success and complexity"
    ],
    "Pending_Relief_or_Application": [
        "Application for costs following trial decision"
    ],
    "Jurisdiction": [
        "Federal Court of Canada"
    ],
    "Governing_Rule": [
        "Federal Courts Rules, Rule 400(3)"
    ]
}